Researchers at National Cancer Institute (NCI) Publish New Data on Rhabdomyosarcomas (Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma)

  • William Figg

Press/Media

Period11 Sep 2023

Media coverage

1

Media coverage